Cencora Inc (COR)

$361.75 -1.81 (-0.50%)
Market Cap 69.69B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 22.02
Forward PE 19.99
Profit Margin 0.48%
Debt to Equity Ratio 4.38
Volume 1,391,200
Avg Vol 1,324,108
Day's Range N/A - N/A
Shares Out 193.99M
Stochastic %K 78%
Beta 0.66
Analysts Strong Sell
Price Target $404.73

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
OptionRunners
OptionRunners Feb. 3 at 8:41 PM
$COR big 2027 call buyer again ahead of earnings in the morning. Had one last week as well
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:16 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:13 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 2:24 PM
$PMN fast track designation and DSMB approval and with this news $175 MILLION in the pocket ready to fly 🛫🚀 https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $CAH $CI $COR $MCK
1 · Reply
Sunny3999
Sunny3999 Jan. 30 at 2:01 PM
$PMN before news of $175 million I wrote this will be a 10bagger $CAH $CI $COR $MCK $PMN
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 1:18 PM
$PMN News $175 million private placement and boom 💥 https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Jan. 28 at 8:05 PM
$PMN $PMN take a look 👀 at the hidden gem 💎 $MCK $COR $CI $CAH
0 · Reply
RunnerSignals
RunnerSignals Jan. 23 at 10:05 PM
$AMC $AMD $CAH $CB $COR get major upgrades today https://stocksrunner.com/news/2026-01-23-analyzing-today-top-stock-upgrades
0 · Reply
IN0V8
IN0V8 Jan. 22 at 3:27 PM
$COR Opportunity Jefferies raises to buy from hold; raises target price to $440 from $330
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 14 at 5:30 PM
$COR Current Stock Price: $348.91 Contracts to trade: $350 COR Jan 16 2026 Call Entry: $2.75 Exit: $3.49 ROI: 27% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on COR
Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Jan 22, 2026, 9:00 AM EST - 12 days ago

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 12 days ago

Cencora Elects Ellen Cooper to Its Board of Directors

Cencora: High-Growth Specialty Services Firm Disguised As A Distributor

Jan 21, 2026, 8:06 AM EST - 13 days ago

Cencora: High-Growth Specialty Services Firm Disguised As A Distributor

Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 2:36 PM EST - 22 days ago

Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Jan 6, 2026, 4:30 PM EST - 4 weeks ago

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Cencora to take majority control of OneOncology to expand cancer services

Dec 15, 2025, 7:11 AM EST - 7 weeks ago

Cencora to take majority control of OneOncology to expand cancer services

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Dec 15, 2025, 7:00 AM EST - 7 weeks ago

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Dec 3, 2025, 7:30 AM EST - 2 months ago

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 3:33 PM EST - 2 months ago

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 2, 2025, 12:53 PM EST - 2 months ago

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora: Earnings Visibility Driving Re-Rating Potential

Nov 7, 2025, 2:05 PM EST - 3 months ago

Cencora: Earnings Visibility Driving Re-Rating Potential

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Nov 5, 2025, 4:01 PM EST - 3 months ago

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Nov 5, 2025, 7:44 AM EST - 3 months ago

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Nov 5, 2025, 7:00 AM EST - 3 months ago

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Nov 5, 2025, 7:00 AM EST - 3 months ago

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Nov 5, 2025, 6:30 AM EST - 3 months ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

Nov 1, 2025, 11:15 PM EDT - 3 months ago

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

ABBV ADP AEP AIZ AOS ATO BDX

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Oct 16, 2025, 9:00 AM EDT - 3 months ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 4 months ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

MCK WFC

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Oct 6, 2025, 4:30 PM EDT - 4 months ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:05 PM EDT - 5 months ago

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 6:02 PM EDT - 5 months ago

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 11:11 AM EDT - 5 months ago

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 5 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Aug 12, 2025, 2:31 PM EDT - 6 months ago

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 8, 2025, 5:08 PM EDT - 6 months ago

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 12:25 PM EDT - 6 months ago

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty drugs

Aug 6, 2025, 7:51 AM EDT - 6 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 6 months ago

Cencora Reports Fiscal 2025 Third Quarter Results

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Jul 3, 2025, 7:30 AM EDT - 7 months ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 8 months ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 16, 2025, 8:37 AM EDT - 9 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 2:06 PM EDT - 9 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 9 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 9 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 10 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 11 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Mar 28, 2025, 7:00 AM EDT - 11 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 1 year ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:37 PM EST - 1 year ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

Feb 6, 2025, 8:30 PM EST - 1 year ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 6, 2025, 8:30 AM EST - 1 year ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 1 year ago

Cencora (COR) Q1 2025 Earnings Call Transcript

Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 1 year ago

Cencora raises 2025 profit forecast on specialty drug demand

Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 1 year ago

Cencora Reports Fiscal 2025 First Quarter Results

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Jan 27, 2025, 7:30 AM EST - 1 year ago

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

HROW

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

Jan 13, 2025, 12:07 PM EST - 1 year ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COST DHR EL MSGS WST

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Jan 8, 2025, 7:30 AM EST - 1 year ago

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 1 year ago

Cencora raises annual profit forecast

Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 1 year ago

Cencora Completes Acquisition of Retina Consultants of America

OptionRunners
OptionRunners Feb. 3 at 8:41 PM
$COR big 2027 call buyer again ahead of earnings in the morning. Had one last week as well
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:16 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:13 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 2:24 PM
$PMN fast track designation and DSMB approval and with this news $175 MILLION in the pocket ready to fly 🛫🚀 https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $CAH $CI $COR $MCK
1 · Reply
Sunny3999
Sunny3999 Jan. 30 at 2:01 PM
$PMN before news of $175 million I wrote this will be a 10bagger $CAH $CI $COR $MCK $PMN
0 · Reply
Sunny3999
Sunny3999 Jan. 30 at 1:18 PM
$PMN News $175 million private placement and boom 💥 https://www.promisneurosciences.com/news-media/press-releases/detail/261/promis-neurosciences-announces-up-to-175-million-private $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Jan. 28 at 8:05 PM
$PMN $PMN take a look 👀 at the hidden gem 💎 $MCK $COR $CI $CAH
0 · Reply
RunnerSignals
RunnerSignals Jan. 23 at 10:05 PM
$AMC $AMD $CAH $CB $COR get major upgrades today https://stocksrunner.com/news/2026-01-23-analyzing-today-top-stock-upgrades
0 · Reply
IN0V8
IN0V8 Jan. 22 at 3:27 PM
$COR Opportunity Jefferies raises to buy from hold; raises target price to $440 from $330
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 14 at 5:30 PM
$COR Current Stock Price: $348.91 Contracts to trade: $350 COR Jan 16 2026 Call Entry: $2.75 Exit: $3.49 ROI: 27% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
IN0V8
IN0V8 Jan. 13 at 6:02 PM
$COR Buy Baird raises target price to $415 from $392
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 2:29 PM
$CAH, $MCK, and $COR are quietly outpacing the market — here’s why! 🚀 🔍 Cardinal Health’s double-digit earnings growth and pending acquisition of Solaris Health signal a robust turnaround with a Zacks Rank #2. 📈 McKesson’s scale drives a 10% revenue jump, and management raised full-year EPS guidance with a Zacks Rank #3. 💡 Cencora’s specialty focus and strategic investments for future growth underpin its Zacks Rank #3. Discover the full breakdown of these under-the-radar winners here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-body-28367&ADID=SYND_STOCKTWITS_TWEET_2_2815489_BODY_28367
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 1:29 PM
Three medical supplies stocks beating the market — even with macro pressure mounting 👀 $CAH, $MCK, and $COR are showing how scale, specialty focus, and strong execution can still deliver market-beating returns while macro headwinds pressure the broader space. Want to see what’s driving the outperformance? Full breakdown here 👉 https://www.zacks.com/stock/news/2815489/3-medical-supplies-stocks-that-beat-the-market-despite-macro-headwinds?cid=sm-stocktwits-2-2815489-teaser-28366&ADID=SYND_STOCKTWITS_TWEET_2_2815489_TEASER_28366
0 · Reply
SilentJoker34
SilentJoker34 Jan. 9 at 1:52 AM
$OTLK Did aezs have an approved drug in uk & Germany with revenues? With many more countries coming 2026-2027? Did aezs have a distribution contract with $COR ? Did aezs have 2 more drugs in phase 3 clinical trials? Fda isn't the end all be all...💎🧐🪖
1 · Reply
ZacksResearch
ZacksResearch Jan. 8 at 5:23 PM
$COR Positioned for Growth Despite Challenges Cencora’s U.S. Healthcare Solutions and specialty drug demand drive its growth prospects, with a projected 11.9% bottom-line improvement over the next five years. However, international segment weakness and competition pose challenges. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2814032/heres-why-you-should-retain-cencora-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2814032-body-28030&ADID=SYND_STOCKTWITS_TWEET_2_2814032_BODY_28030
0 · Reply
ZacksResearch
ZacksResearch Jan. 8 at 4:23 PM
$COR — why holding Cencora right now actually makes sense 📊 Cencora’s strength in U.S. Healthcare Solutions, rising specialty drug demand, and growing biosimilar adoption continue to support its growth outlook, even as competitive pressures and international weakness remain real headwinds. Get the full bull/bear case here 👉 https://www.zacks.com/stock/news/2814032/heres-why-you-should-retain-cencora-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2814032-teaser-28029&ADID=SYND_STOCKTWITS_TWEET_2_2814032_TEASER_28029
0 · Reply
TeresaOsterhoudt909
TeresaOsterhoudt909 Jan. 6 at 5:13 PM
$CP $AJG $RACE $RSG $COR Great structure
0 · Reply
Creisi
Creisi Jan. 5 at 4:08 PM
$AFL $COR $MLTX $REGN $SOC Another bullshit ad. MLTX is not a billboard for your bullshit ads. Fuck off! It's for MLTX news and discussion.
0 · Reply
CrazyChief
CrazyChief Jan. 2 at 3:47 PM
$OTLK $COR Where is Bob???.?
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 31 at 6:23 PM
$COR RSI: 48.68, MACD: -2.3446 Vol: 3.26, MA20: 340.88, MA50: 348.07 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DorotheaNewell809
DorotheaNewell809 Dec. 31 at 5:49 PM
$CP $AJG $RACE $RSG $COR Great structure
0 · Reply
Altairus
Altairus Dec. 31 at 4:14 AM
$OTLK $COR
0 · Reply